Commentary by Dr Jiang Jun
Audio Summary of the March Issue with Introduction by Dr. Bonnie Ky.
Commentary by Gabriel Aleixo
Commentary by Brian Jensen
Commentary by Saro Armenian
Commentary by Saro Armenian
Commentary by Corralea Kappel
Commentary by Yugo Yamashita
Commentary by Bonnie Ky
JACC: CardioOncology Editor-in-chief, Bonnie Ky, MD, MSCE, FACC and David Austin, MD, FRCP discuss PROACT, a phase three randomized open label blinded endpoint superiority trial of enalapril to prevent anthracycline induced cardiotoxicity.
Drs. Eugene Yang and Amber Tang discuss social determinants and impact on cardiovascular risk factors among disaggregated Asian subgroups.
Audio Summary of the April 1, 2024 Issue by Dr. Jian'an Wang
Commentary by Dr. Abdullah Al-Abcha and Dr. John Blair
Commentary by Dr Dong Zhao
Commentary by Dr Pranav M. Patel
Commentary by Dr Yundai Chen
Commentary by Dr. Mirza Umair Khalid and Dr. Mohamed Abdel-Wahab
Commentary by Dr. Mirza Umair Khalid and Dr. Oriol Rodriguez-Leor
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides